Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 29 symbols : Jnj save search
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
EBS | News | $2.18 -4.8% 0.0% 800K
|
Health Technology
|
| O: 1.66%
H: 2.7%
C: -1.54%
covid vaccine merge covid-19
COVID News: EUA Expanded for Baricitinib, Emergent Starts to Manufacture J&J Vaccine Again and More
Published: 2021-07-29 (Crawled : 16:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
covid baricitinib vaccine merge
Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
women cancer
Biologics Market Size to Reach USD 477.15 Billion in 2027 | Rapid Advancements in Molecular Therapy and Cell-Based Biologics, Increasing Incidence of Chronic Diseases, are Some Key Factors Driving Industry Growth, says Emergen Research
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
disease therapy molecular growth research merge
$ 26.35 Bn growth expected in Baby Care Products Market in India | Analyzing Growth in Housewares & Specialties Industry | Technavio
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
india growth
Pfizer-BioNTech Vaccine: African Deal, $34 Billion in Sales, and Efficacy Drop
Published: 2021-07-29 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
sales drop vaccine
Customization of Implants, Decline in Post-operation Discomfort to Drive Hip Replacement Implants Market at CAGR of 4% during Forecast Period, Says TMR
Published: 2021-07-29 (Crawled : 14:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
implant
Adagio Therapeutics Appoints Leading Pharmaceutical and Regulatory Executives to its Board of Directors
Published: 2021-07-29 (Crawled : 12:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
RDUS | $17.9 1.47% 1.45% 320K
|
Health Technology
|
| O: 1.14%
H: 1.4%
C: -5.56%
MREO | $2.785 0.18% 0.18% 570K
|
Health Technology
|
| O: -0.73%
H: 2.51%
C: -3.68%
AKBA | $1.36 -0.73% -0.74% 1.5M
|
Health Technology
|
| O: -0.38%
H: 1.71%
C: -4.18%
Macomics, the Macrophage-based Drug Discovery company, secures £4.24m expansion financing, and appoints CEO, CSO and VP Immunology
Published: 2021-07-29 (Crawled : 09:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
expansion immunology drug discovery drug ceo
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.